GeneNews Stock Price, News & Analysis (TSE:GEN)

C$0.11 -0.01 (-8.33 %)
(As of 02/20/2018 04:00 PM ET)
Previous CloseC$0.12
Today's RangeC$0.11 - C$0.12
52-Week RangeC$0.08 - C$0.53
Volume601,700 shs
Average Volume606,889 shs
Market CapitalizationC$13.75 million
P/E Ratio-4.00
Dividend YieldN/A
Beta10.01

About GeneNews (TSE:GEN)

GeneNews Ltd is a Canada-based company focused on developing and commercializing proprietary molecular diagnostic tests for early detection of cancer. It has developed Sentinel Principle platform technology, which determines biomarkers from whole blood. In additional, the Company offers ColonSentry product, it is a blood test to determine an individual’s current risk for having colorectal cancer. The Company operates within the biotechnology, molecular diagnostic and genomic biomarker industry. GeneNews has subsidiaries in Canada and the United states. The Company’s partners include JTS Health Partners and NueHealth, which are located in the United States.

Receive GEN News and Ratings via Email

Sign-up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorHealthcare
SymbolTSE:GEN
CUSIPN/A
Phone+1-905-7392030

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-4
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSC($0.03)
Net IncomeN/A
Net Margins-1,108.58%
Return on EquityN/A
Return on Assets-81.53%

Miscellaneous

EmployeesN/A
Outstanding Shares104,670,000

GeneNews (TSE:GEN) Frequently Asked Questions

What is GeneNews' stock symbol?

GeneNews trades on the Toronto Stock Exchange (TSX) under the ticker symbol "GEN."

How were GeneNews' earnings last quarter?

GeneNews Ltd (TSE:GEN) announced its quarterly earnings data on Thursday, May, 15th. The company reported ($0.02) EPS for the quarter, topping the Zacks' consensus estimate of ($0.04) by $0.02. The company had revenue of $0.20 million for the quarter, compared to analyst estimates of $0.04 million. View GeneNews' Earnings History.

When will GeneNews make its next earnings announcement?

GeneNews is scheduled to release their next quarterly earnings announcement on Monday, April, 2nd 2018. View Earnings Estimates for GeneNews.

Who are some of GeneNews' key competitors?

Who are GeneNews' key executives?

GeneNews' management team includes the folowing people:

  • James R. Howard-Tripp, Chairman of the Board, Chief Executive Officer
  • Leslie Auld, Chief Financial Officer, Treasurer, Director
  • Heinrich Dreismann Ph.D., Lead Director (Age 64)
  • Harry A. Glorikian, Independent Director (Age 50)
  • Rory B. Riggs, Independent Director (Age 64)

How do I buy GeneNews stock?

Shares of GeneNews and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is GeneNews' stock price today?

One share of GeneNews stock can currently be purchased for approximately C$0.11.

How big of a company is GeneNews?

GeneNews has a market capitalization of C$13.75 million.

How can I contact GeneNews?

GeneNews' mailing address is 445 Apple Creek Blvd Unit 220, MARKHAM, ON L3R 9X7, Canada. The company can be reached via phone at +1-905-7392030.


MarketBeat Community Rating for GeneNews (GEN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  29 (Vote Underperform)
Total Votes:  54
MarketBeat's community ratings are surveys of what our community members think about GeneNews and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

GeneNews (TSE:GEN) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

GeneNews (TSE:GEN) Earnings History and Estimates Chart

Earnings by Quarter for GeneNews (TSE:GEN)

GeneNews (TSE GEN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/2/2018        
11/14/2017Q3 2017C($0.01)ViewN/AView Earnings Details
8/14/2017Q2 2017C($0.01)ViewN/AView Earnings Details
5/11/2017Q1 2017C($0.02)ViewN/AView Earnings Details
4/3/2017Q4 2016C$0.08ViewN/AView Earnings Details
11/11/2016Q3 2016C($0.05)ViewN/AView Earnings Details
8/11/2016Q2 2016C($0.03)ViewN/AView Earnings Details
6/15/2016Q1 2016C($0.07)ViewN/AView Earnings Details
5/27/2016Q4 2015C($0.03)ViewN/AView Earnings Details
11/13/2015Q3 2015C($0.05)ViewN/AView Earnings Details
8/14/2015Q2 2015C($0.03)ViewN/AView Earnings Details
5/14/2015Q1 2015C($0.02)ViewN/AView Earnings Details
3/31/2015Q4 2014C($0.04)C($0.04)ViewN/AView Earnings Details
11/12/2014Q3 2014C($0.05)C($0.02)ViewN/AView Earnings Details
8/8/2014Q2 2014C($0.04)C($0.02)ViewN/AView Earnings Details
5/15/2014C($0.04)C($0.02)C$0.04 millionC$0.20 millionViewN/AView Earnings Details
3/4/2014Q4 2013C($0.05)C($0.06)ViewN/AView Earnings Details
11/14/2013Q3 2013C($0.05)C($0.06)ViewN/AView Earnings Details
8/9/2013Q2 2013C($0.05)C($0.06)ViewN/AView Earnings Details
5/15/2013Q1 2013C($0.05)ViewN/AView Earnings Details
3/26/2013Q4 2012C($0.05)ViewN/AView Earnings Details
11/12/2012Q3 2012C($0.06)ViewN/AView Earnings Details
8/9/2012Q2 2012C($0.06)ViewN/AView Earnings Details
5/11/2012Q1 2012C($0.06)ViewN/AView Earnings Details
3/26/2012Q4 2011C($0.06)ViewN/AView Earnings Details
10/27/2011Q3 2011C($0.06)ViewN/AView Earnings Details
8/10/2011Q2 2011C($0.06)ViewN/AView Earnings Details
5/18/2011Q1 2011C($0.12)ViewN/AView Earnings Details
3/25/2011Q4 2010C($0.06)ViewN/AView Earnings Details
11/15/2010Q3 2010C($0.12)ViewN/AView Earnings Details
8/11/2010Q2 2010C($0.11)ViewN/AView Earnings Details
5/4/2010Q1 2010C($0.13)ViewN/AView Earnings Details
3/15/2010Q4 2009C($0.02)ViewN/AView Earnings Details
11/11/2009Q3 2009C($0.13)ViewN/AView Earnings Details
8/14/2009Q2 2009C($0.19)ViewN/AView Earnings Details
5/14/2009Q1 2009C($0.21)ViewN/AView Earnings Details
3/31/2009Q4 2008C($0.30)ViewN/AView Earnings Details
11/14/2008Q3 2008C($0.42)ViewN/AView Earnings Details
8/7/2008Q2 2008C($0.43)ViewN/AView Earnings Details
5/2/2008Q1 2008C($0.28)ViewN/AView Earnings Details
3/26/2008Q4 2007C($0.30)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

GeneNews (TSE:GEN) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for GeneNews (TSE:GEN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for GeneNews (TSE GEN)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

GeneNews (TSE GEN) News Headlines

Source:
DateHeadline
BRIEF-Update On Milost Equity Subscription Agreement (MESA)BRIEF-Update On Milost Equity Subscription Agreement (MESA)
www.reuters.com - February 8 at 9:57 AM
Update on Milost Equity Subscription Agreement (MESA)Update on Milost Equity Subscription Agreement (MESA)
finance.yahoo.com - February 8 at 9:57 AM
Should You Be Concerned About GeneNews Limited’s (TSE:GEN) Shareholders?Should You Be Concerned About GeneNews Limited’s (TSE:GEN) Shareholders?
finance.yahoo.com - January 29 at 5:26 PM
What Kind Of Risk And Return Should You Expect For GeneNews Limited (TSE:GEN)?What Kind Of Risk And Return Should You Expect For GeneNews Limited (TSE:GEN)?
finance.yahoo.com - January 5 at 5:38 PM
Today’s Research Reports on GeneNews Limited, Knight Therapeutics Inc., Revive Therapeutics Ltd. and Fennec Pharmaceuticals Inc.Today’s Research Reports on GeneNews Limited, Knight Therapeutics Inc., Revive Therapeutics Ltd. and Fennec Pharmaceuticals Inc.
finance.yahoo.com - January 5 at 8:58 AM
GeneNews Limited’s (TSX:GEN) EPS Grew 88.1% In A Year. Was It Better Than Long-Term Trend?GeneNews Limited’s (TSX:GEN) EPS Grew 88.1% In A Year. Was It Better Than Long-Term Trend?
finance.yahoo.com - December 8 at 5:46 PM
GeneNews Ltd (GEN) Set to Announce Earnings on WednesdayGeneNews Ltd (GEN) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - November 14 at 9:12 AM
GeneNews to Report Third Quarter 2017 Financial Results on November 15, 2017 - Conference Call to Follow - PR Newswire (press release)GeneNews to Report Third Quarter 2017 Financial Results on November 15, 2017 - Conference Call to Follow - PR Newswire (press release)
www.prnewswire.com - November 13 at 7:15 PM
GeneNews to Report Third Quarter 2017 Financial Results on November 15, 2017 - Conference Call to FollowGeneNews to Report Third Quarter 2017 Financial Results on November 15, 2017 - Conference Call to Follow
finance.yahoo.com - November 13 at 9:44 AM
GeneNews Closes The $10 Million Milost FinancingGeneNews Closes The $10 Million Milost Financing
finance.yahoo.com - November 11 at 5:45 AM
GeneNews Announces Q2-2017 Financial Results & Provides Progress Update - MarketWatchGeneNews Announces Q2-2017 Financial Results & Provides Progress Update - MarketWatch
www.marketwatch.com - August 15 at 7:37 PM
GeneNews Announces Q2-2017 Financial Results & Provides Progress UpdateGeneNews Announces Q2-2017 Financial Results & Provides Progress Update
finance.yahoo.com - August 15 at 7:37 PM
GeneNews reports 2Q lossGeneNews reports 2Q loss
finance.yahoo.com - August 15 at 7:37 PM
GeneNews Ltd. (TSE:GEN) Set to Announce Quarterly Earnings on TuesdayGeneNews Ltd. (TSE:GEN) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - August 10 at 12:20 PM

SEC Filings

GeneNews (TSE:GEN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

GeneNews (TSE GEN) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.